Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
C1q is part of the C1 macromolecular complex that mediates the classical complement activation pathway, a major arm of innate immune defence. C1q is composed of A, B, and C chains that require post-translational prolyl-4-hydroxylation of their N-terminal collagen-like domain to enable formation of t...
Main Authors: | Kiriakidis, S, Hoer, S, Burrows, N, Biddlecome, G, Khan, M, Thinnes, C, Schofield, C, Rogers, N, Botto, M, Paleolog, E, Maxwell, P |
---|---|
Format: | Journal article |
Published: |
Elsevier
2017
|
Similar Items
-
Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010) -
2-oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2
by: Abboud, M, et al.
Published: (2018) -
Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma
by: Atkinson, Aithne, et al.
Published: (2020) -
Collagen Prolyl 4-Hydroxylase as a Therapeutic Target
by: Vasta, James D., et al.
Published: (2020) -
Inhibition of a viral prolyl hydroxylase
by: Langley, G, et al.
Published: (2019)